Skip to content

Effect of hydrogen inhalation on brain injury in patients with subarachnoid hemorrhage: an open parallel randomized controlled trial

Effect of hydrogen inhalation in the treatment of subarachnoid hemorrhage

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059060
Enrollment
Unknown
Registered
2022-04-23
Start date
2022-04-23
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid hemorrhage

Interventions

Treatment group:3% hydrogen inhalation
Control group:Routine oxygen inhalation

Sponsors

Department of Neurosurgery, The Affiliated Drum Tower Hospital, School of Medicine, Nanjing University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient or entrusted family members voluntarily signed the informed consent for this test; 2. Aged from 20 years to 70 years old, regardless of gender; 3. SAH patients with ruptured aneurysms; 4. Interventional therapy was completed within 72 hours after the aneurysm rupture.

Exclusion criteria

Exclusion criteria: 1. Patients are judged by the responsible physician to be unfit to participate in the study; 2. Patients with severe cardiac insufficiency, pulmonary insufficiency, liver insufficiency, or kidney insufficiency; 3. Patients with massive intracranial hematoma; 4. Patients undergo craniotomy for clipping aneurysms; 5. Patients who reject random grouping; 6. Any reasons for not being selected by the researcher.

Design outcomes

Primary

MeasureTime frame
Neurological function assessment;

Secondary

MeasureTime frame
Brain edema;cerebral vasospasm;Nerve injury marker levels;Oxidative stress level;Inflammation levels;The lactic acid level;Brain electrical activity;

Countries

China

Contacts

Public ContactZong Zhuang

The Affiliated Drum Tower Hospital, School of Medicine, Nanjing University

zhuangzong@126.com+86 15850560410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026